This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

  • New TB Vaccine Enters Clinical Testing
    At an international gathering of TB vaccine researchers in Tallinn, Estonia today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis ...More
    September 23, 2010 Posted in News
  • City Living Helped Humans Evolve Immunity to TB
    New research has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living. The research, published in the journal Evolution, shows that in areas with a ...More
    September 23, 2010 Posted in News
  • Scientists Reveal Structure of Bacteria's Powerful Multidrug Resistance Pump
    A team at the Scripps Research Institute has detailed the structure of a member of the only remaining class of multidrug resistance transporters left to be described. The work has implications for combating dangerous antibiotic resistant strains of bacteria, as well as for ...More
    September 23, 2010 Posted in News
  • Salmonella Creates Environment in Human Intestines to Foster its Own Growth
    A study led by researchers at UC Davis has found how the bacteria Salmonella enterica — a common cause of food poisoning — exploits immune response in the human gut to enhance its own reproductive and transmission success. The strategy gives Salmonella a growth advantage ...More
    September 23, 2010 Posted in News
  • AIDS Drug Could Be Effective Against Herpesvirus
    Scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by the coordinator of the Structural and Computational Biology Programme, Miquel Coll, have published a new study that demonstrates that raltegravir, the drug approved in 2007 for the treatment ...More
    September 23, 2010 Posted in News
  • Decubitus Ulcers are Polymicrobial, Treatment Should be Tailored to Patients' Wound Microflora
    Decubitus ulcers, also known as bedsores or pressure ulcers, affect millions of hospitalized patients each year. The microflora of chronic wounds such as ulcers most commonly exist in the biofilm phenotype and have been known to significantly impair normal healing ...More
    September 22, 2010 Posted in News
  • Eucalyptus Oil Enhances Antiseptic Effect of CHG
    Chlorhexidine gluconate (CHG) is a widely used skin antiseptic, however it poorly penetrates the skin, limiting its efficacy against microorganisms residing beneath the surface layers of skin. Karpanen, et al. (2010) sought to improve the delivery of CHG when used as a skin ...More
    September 22, 2010 Posted in News
  • Report Shows Improvements on Pneumonia, Surgical Care But Not on Antibiotic Prophylaxis
    Accredited hospitals in the United States are providing higher-quality, evidence-based care for pneumonia and surgery, among other conditions according to "Improving America’s Hospitals: The Joint Commission’s Report on Quality and Safety 2010." The report presents ...More
    September 22, 2010 Posted in News
  • Doctors Overprescribe Antibiotics for Respiratory Infections
    Doctors frequently misuse antibiotics when treating patients hospitalized with respiratory tract infections (RTIs), according to a study to be published in the November issue of Infection Control and Hospital Epidemiology. The study, which tracked patients in two ...More
    September 22, 2010 Posted in News
  • New Drug Could Help Stop the Spread of Disease During a Cough
    What if there was a drug that could completely eliminate airborne disease transmission that occurs when someone coughs? Researchers at the University of Alberta believe they have found a way to achieve this. The idea behind this work came from Malcolm King and his research ...More
    September 22, 2010 Posted in News